Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Generation of mouse models of lymphoid neoplasm using retroviral gene transduction of in vitro-induced germinal center B and T cells.

Arita K, Maeda-Kasugai Y, Ohshima K, Tsuzuki S, Suguro-Katayama M, Karube K, Yoshida N, Sugiyama T, Seto M.

Exp Hematol. 2013 Aug;41(8):731-741.e9. doi: 10.1016/j.exphem.2013.04.001. Epub 2013 Apr 9.

PMID:
23583576
2.

Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.

Nakagawa M, Tsuzuki S, Honma K, Taguchi O, Seto M.

Haematologica. 2011 Sep;96(9):1318-26. doi: 10.3324/haematol.2011.041053. Epub 2011 May 23.

3.

Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.

Avilés Mendoza GJ, Seidel NE, Otsu M, Anderson SM, Simon-Stoos K, Herrera A, Hoogstraten-Miller S, Malech HL, Candotti F, Puck JM, Bodine DM.

Mol Ther. 2001 Apr;3(4):565-73.

4.

VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.

Egle A, Harris AW, Bath ML, O'Reilly L, Cory S.

Blood. 2004 Mar 15;103(6):2276-83. Epub 2003 Nov 20.

5.
6.

A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignancies.

Fiancette R, Amin R, Truffinet V, Vincent-Fabert C, Cogné N, Cogné M, Denizot Y.

Leuk Res. 2010 Aug;34(8):1043-51. doi: 10.1016/j.leukres.2009.11.017.

PMID:
20018375
7.

Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.

Shinto Y, Morimoto M, Katsumata M, Uchida A, Aozasa K, Okamoto M, Kurosawa T, Ochi T, Greene MI, Tsujimoto Y.

Oncogene. 1995 Nov 2;11(9):1729-36.

PMID:
7478600
8.

Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells.

Nunez G, Seto M, Seremetis S, Ferrero D, Grignani F, Korsmeyer SJ, Dalla-Favera R.

Proc Natl Acad Sci U S A. 1989 Jun;86(12):4589-93.

9.

Retroviral transduction of IL2RG into CD34(+) cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras.

Tsai EJ, Malech HL, Kirby MR, Hsu AP, Seidel NE, Porada CD, Zanjani ED, Bodine DM, Puck JM.

Blood. 2002 Jul 1;100(1):72-9.

10.

Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.

Strasser A, Harris AW, Bath ML, Cory S.

Nature. 1990 Nov 22;348(6299):331-3.

PMID:
2250704
11.

ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.

Linden M, Kirchhof N, Kvitrud M, Van Ness B.

Leuk Res. 2005 Apr;29(4):435-44. Epub 2004 Dec 18.

PMID:
15725478
13.

Retroviral transduction of enriched hematopoietic stem cells allows lifelong Bcl-2 expression in multiple lineages but does not perturb hematopoiesis.

Innes KM, Szilvassy SJ, Davidson HE, Gibson L, Adams JM, Cory S.

Exp Hematol. 1999 Jan;27(1):75-87.

PMID:
9923446
14.
15.

Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.

Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC 3rd, Janz S.

Cancer Res. 2005 Feb 15;65(4):1306-15.

16.

A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.

Vincent-Fabert C, Fiancette R, Rouaud P, Baudet C, Truffinet V, Magnone V, Guillaudeau A, Cogné M, Dubus P, Denizot Y.

Am J Pathol. 2012 Apr;180(4):1688-701. doi: 10.1016/j.ajpath.2012.01.004. Epub 2012 Feb 9.

PMID:
22326754
17.

v-myc and v-raf act synergistically to induce B-cell tumors in pristane-primed adult BALBC mice.

Kurie JM, Morse HC 3rd, Principato MA, Wax JS, Troppmair J, Rapp UR, Potter M, Mushinski JF.

Oncogene. 1990 Apr;5(4):577-82.

PMID:
2183159
18.

Distinctive cell properties of B cells carrying the BCL2 translocation and their potential roles in the development of lymphoma of germinal center type.

Sakai T, Nishikori M, Tashima M, Yamamoto R, Kitawaki T, Takaori-Kondo A, Suzuki T, Tsuzuki S, Uchiyama T.

Cancer Sci. 2009 Dec;100(12):2361-7. doi: 10.1111/j.1349-7006.2009.01344.x. Epub 2009 Sep 2.

19.

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.

Li S, Lin P, Fayad LE, Lennon PA, Miranda RN, Yin CC, Lin E, Medeiros LJ.

Mod Pathol. 2012 Jan;25(1):145-56. doi: 10.1038/modpathol.2011.147. Epub 2011 Oct 14.

20.

Runx1 promotes B-cell survival and lymphoma development.

Blyth K, Slater N, Hanlon L, Bell M, Mackay N, Stewart M, Neil JC, Cameron ER.

Blood Cells Mol Dis. 2009 Jul-Aug;43(1):12-9. doi: 10.1016/j.bcmd.2009.01.013. Epub 2009 Mar 9.

PMID:
19269865

Supplemental Content

Support Center